Form 4: Elanco Director Receives Annual Equity Award

Denise Scots-Knight, a director at Elanco Animal Health, received 18,169 shares of common stock as part of an annual equity award.

Summary

• Denise Scots-Knight, a director at Elanco Animal Health, received 18,169 shares of common stock on November 29, 2024.
• This transaction was part of an annual equity award for non-employee members of the Board of Directors.
• Following this transaction, Ms. Scots-Knight directly owns 78,400 shares of Elanco common stock.
• The shares were granted at a price of $0.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant to a director, which is a positive but expected event. It does not indicate any significant positive or negative sentiment.

Positives

• The equity award aligns the interests of the director with the company's performance.
• The grant of shares indicates a continued commitment to the company by the director.

Industry Context

Equity awards are a common practice for compensating board members in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Granting equity to non-employee directors is a standard practice across publicly listed companies, including those in the animal health sector.
• Companies like Zoetis and IDEXX Laboratories also use equity grants as part of their director compensation packages.
• The size of the grant is likely determined by the company's compensation policy and the director's role and responsibilities.

Stakeholder Impact

• The equity grant aligns the director's interests with those of shareholders.
• The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Elanco Animal Health, Director, Equity Award, Stock Grant, Beneficial Ownership, Form 4, Denise Scots-Knight